AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Down 22.5% in July

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a large decrease in short interest during the month of July. As of July 15th, there was short interest totalling 93,200 shares, a decrease of 22.5% from the June 30th total of 120,200 shares. Currently, 2.6% of the company’s shares are short sold. Based on an average daily volume of 14,100 shares, the days-to-cover ratio is currently 6.6 days.

AquaBounty Technologies Stock Down 8.4 %

Shares of AquaBounty Technologies stock traded down $0.15 during trading on Tuesday, reaching $1.59. 37,109 shares of the company traded hands, compared to its average volume of 22,911. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.26 and a quick ratio of 0.23. AquaBounty Technologies has a 1-year low of $1.53 and a 1-year high of $8.00. The company has a 50 day moving average price of $1.73 and a 200-day moving average price of $2.00. The firm has a market capitalization of $6.12 million, a PE ratio of -0.18 and a beta of 1.18.

AquaBounty Technologies (NASDAQ:AQB) last released its earnings results on Wednesday, May 15th. The company reported ($1.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.42) by ($0.11). AquaBounty Technologies had a negative net margin of 1,263.43% and a negative return on equity of 16.07%. The company had revenue of $0.48 million for the quarter, compared to analyst estimates of $0.50 million. As a group, equities research analysts expect that AquaBounty Technologies will post -4.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on AQB shares. Oppenheimer reaffirmed a “market perform” rating on shares of AquaBounty Technologies in a research note on Tuesday, April 2nd. HC Wainwright reaffirmed a “neutral” rating on shares of AquaBounty Technologies in a research note on Thursday, May 16th.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.